$90.00
Unleash the ultimate regenerative powerhouse in your laboratory with the Wolverine Blend (BPC-157 + TB-500), the legendary peptide synergy inspired by rapid, unstoppable tissue restoration. Masterfully engineered to combine the blood-vessel-building mastery of BPC-157 with the cellular-remodeling agility of TB-500, this elite formulation attacks structural damage, cellular stress, and inflammation from every possible biological angle. Whether you are pioneering breakthrough recovery models for severe musculoskeletal injuries, exploring accelerated wound closure, or investigating multi-tissue cytoprotection, our ultra-pure, HPLC-verified Wolverine Blend delivers the extreme potency, unmatched speed, and uncompromising precision required to turn your most ambitious regenerative experiments into scientific reality.
Per vial
Form
Purity
CAS #
Molecular Formula
Molecular Weight
Half-life
Origin
Development Stage
Mechanism
The Gold Standard Synergy for Accelerated Tissue Repair & Cytoskeletal Remodeling
Investigate the forefront of regenerative biology, musculoskeletal recovery, and cellular repair with the Wolverine Blend (BPC-157 + TB-500), a premier dual-action peptide formulation engineered for intensive laboratory research into structural tissue restoration. This masterfully synchronized combination unites Body Protective Compound 157 (BPC-157)—a 15-amino acid synthetic peptide derived from human gastric juice—with Thymosin Beta-4 (TB-500), a 43-amino acid endogenous actin-sequestering protein. By engaging two completely distinct yet highly complementary physiological pathways, this synergistic blend targets cellular damage, inflammation, and structural breakdown from multiple upstream angles simultaneously.
When administered together, BPC-157 and TB-500 create a profound biological compounding effect that individual peptides cannot achieve in isolation. While BPC-157 operates at the vascular and endothelial level by upregulating vascular endothelial growth factor receptor 2 (VEGFR2) and activating the Akt-eNOS nitric oxide pathway to drive rapid angiogenesis and localized cytoprotection, TB-500 circulates systemically to sequester monomeric G-actin via its core LKKTET motif. This simultaneous stimulation of new blood vessel formation alongside dynamic cytoskeletal remodeling accelerates fibroblast proliferation, stem cell migration, and extracellular matrix (ECM) reorganization—providing researchers with an extraordinary model for studying rapid, scar-free healing in tendons, ligaments, muscle fibers, and gastrointestinal mucosa.
Dual-Mechanism Synergy: Synchronizes the potent angiogenic and cytoprotective signaling of BPC-157 with the actin-sequestering and cell-migratory mastery of TB-500 in a single, high-efficiency research formulation.
Accelerated Angiogenesis & Vascular Repair (BPC-157): Upregulates VEGFR2 expression and stimulates nitric oxide production via the Akt-eNOS cascade, rapidly restoring microvascular blood flow and nutrient delivery to ischemic or damaged tissue beds.
Actin Sequestration & Cell Migration (TB-500): Utilizes the conserved LKKTET amino acid motif (residues 17–23) to bind G-actin and dynamically control cytoskeletal architecture, enabling rapid keratinocyte and stem cell locomotion to sites of injury.
Comprehensive Musculoskeletal Recovery: Extensively validated in preclinical literature to accelerate healing models across torn tendons, damaged ligaments, strained muscle fibers, and bone-to-tendon junction injuries.
Cytoprotection & Anti-Inflammatory Signaling: Suppresses the infiltration of pro-inflammatory cytokines, downregulates oxidative stress cascades, and protects epithelial and endothelial cell membranes against apoptotic cell death.
Ultra-Pure Specification: Lyophilized and synthesized at an elite ≥99% purity level (HPLC and Mass Spectrometry verified) to guarantee uncompromising analytical precision and zero contaminant interference in complex laboratory assays.
This product is intended for laboratory research use only (RUO). Not for human or veterinary use.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Peak Vitality peptides have not been approved by Health Canada. Products by Peak Vitality have not been assessed for safety, efficacy and/or quality, may pose a range of serious health risks, and are intended for research purposes only. Products sold under Peak Vitality are not intended to treat, cure, or prevent diseases and/or conditions and may cause serious side effects.